| Title : The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin - He_2007_Eur.J.Clin.Pharmacol_63_677 |
| Author(s) : He YL , Sabo R , Campestrini J , Wang Y , Ligueros-Saylan M , Lasseter KC , Dilzer SC , Howard D , Dole WP |
| Ref : European Journal of Clinical Pharmacology , 63 :677 , 2007 |
| Abstract : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| ESTHER : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| PubMedSearch : He_2007_Eur.J.Clin.Pharmacol_63_677 |
| PubMedID: 17486328 |
He YL, Sabo R, Campestrini J, Wang Y, Ligueros-Saylan M, Lasseter KC, Dilzer SC, Howard D, Dole WP (2007)
The influence of hepatic impairment on the pharmacokinetics of the dipeptidyl peptidase IV (DPP-4) inhibitor vildagliptin
European Journal of Clinical Pharmacology
63 :677
He YL, Sabo R, Campestrini J, Wang Y, Ligueros-Saylan M, Lasseter KC, Dilzer SC, Howard D, Dole WP (2007)
European Journal of Clinical Pharmacology
63 :677